• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

COVID-19 患者的心包细胞因子“风暴”:假设的验证。

Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis.

机构信息

Department of Anesthesia and Intensive Care Medicine, Academic Hospital of Udine, Piazzale S.M. della Misericordia, 15, 33100, Udine, Italy.

Department of Medicine, University of Udine, Udine, Italy.

出版信息

Inflammation. 2022 Feb;45(1):1-5. doi: 10.1007/s10753-021-01563-3. Epub 2021 Sep 17.

DOI:10.1007/s10753-021-01563-3
PMID:34533672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8446479/
Abstract

Novel Coronavirus Disease in most cases produces mild symptoms which resolve after a few days. Some authors hypothesized that SARS-CoV-2 infection could trigger excessive cytokine production leading to a severe multi-organ disease requiring intensive care admission. Respiratory and neurological symptoms are the most frequently reported manifestation of the disease. Indeed, cardiac involvement is reported mostly as a part of a systemic disease. Few isolated cardiac manifestations of COVID-19 infection have been described. We report herein a case of SARS-CoV-2 related severe isolated pericardial involvement requiring ICU admission due to cardiac tamponade needing urgent drainage. Analysis of pericardial fluid from drainage demonstrated a higher cytokine concentration than blood values. Other causes of pericardial disease, such as autoimmunity, bacterial or other than COVID-19 infection, neoplasms or acute myocardial infarction were also evaluated, but all tests confirmed negative results. The suspicion of isolated involvement of the pericardium was therefore demonstrated by the analysis of cytokines which strongly support our hypothesis.

摘要

新型冠状病毒病在大多数情况下产生轻微症状,几天后即可缓解。一些作者假设,SARS-CoV-2 感染可能会引发过度的细胞因子产生,导致需要重症监护入院的严重多器官疾病。呼吸道和神经系统症状是该疾病最常报告的表现。实际上,心脏受累主要作为全身性疾病的一部分报告。已经描述了少数孤立的 COVID-19 感染的心脏表现。我们在此报告了一例与 SARS-CoV-2 相关的严重孤立性心包受累的病例,由于心脏压塞需要紧急引流,因此需要入住 ICU。引流的心包液分析显示细胞因子浓度高于血液值。还评估了其他引起心包疾病的原因,如自身免疫、细菌或非 COVID-19 感染、肿瘤或急性心肌梗死,但所有检查均证实为阴性结果。通过对细胞因子的分析证实了心包的孤立受累的怀疑,这强烈支持了我们的假设。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/8446479/2d05306b7ee7/10753_2021_1563_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/8446479/dcffd1d23607/10753_2021_1563_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/8446479/2d05306b7ee7/10753_2021_1563_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/8446479/dcffd1d23607/10753_2021_1563_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdee/8446479/2d05306b7ee7/10753_2021_1563_Fig2_HTML.jpg

相似文献

1
Pericardial Cytokine "Storm" in a COVID-19 Patient: the Confirmation of a Hypothesis.COVID-19 患者的心包细胞因子“风暴”:假设的验证。
Inflammation. 2022 Feb;45(1):1-5. doi: 10.1007/s10753-021-01563-3. Epub 2021 Sep 17.
2
The Diagnostic Value of Pericardial Fluid and Pericardial Biopsy: Single Center Experiences.心包积液与心包活检的诊断价值:单中心经验
Heart Surg Forum. 2016 Feb 23;19(1):E23-7. doi: 10.1532/hsf.1328.
3
Coronavirus Disease 2019 (COVID-19) and Severe Pericardial Effusion: From Pathogenesis to Management: A Case Report Based Systematic Review.新型冠状病毒病 2019(COVID-19)与严重心包积液:从发病机制到管理:基于系统评价的病例报告。
Curr Probl Cardiol. 2022 Feb;47(2):100933. doi: 10.1016/j.cpcardiol.2021.100933. Epub 2021 Jul 24.
4
Acute Myopericarditis with Pericardial Effusion and Cardiac Tamponade in a Patient with COVID-19.一名新冠肺炎患者出现急性心肌心包炎伴心包积液和心脏压塞
Am J Case Rep. 2020 Jul 1;21:e925554. doi: 10.12659/AJCR.925554.
5
Pericardial tamponade and large pericardial effusions: causal factors and efficacy of percutaneous catheter drainage in 50 patients.心包填塞与大量心包积液:50例患者的病因及经皮导管引流的疗效
Tex Heart Inst J. 2004;31(4):398-403.
6
A rare presentation of a patient with COVID-19: Cardiac tamponade.一名新冠肺炎患者的罕见表现:心脏压塞。
Turk Kardiyol Dern Ars. 2020 Oct;48(7):703-706. doi: 10.5543/tkda.2020.56727.
7
Pericardial Diseases in COVID19: a Contemporary Review.COVID19 相关的心包疾病:当代综述。
Curr Cardiol Rep. 2021 Jun 3;23(7):90. doi: 10.1007/s11886-021-01519-x.
8
Life-Threatening Cardiac Tamponade Secondary to COVID-19 Treated with Uniportal Video-Assisted Thoracoscopic Surgery: A Case Report.COVID-19 所致危及生命的心包填塞采用单孔电视辅助胸腔镜手术治疗:病例报告。
Am J Case Rep. 2022 Apr 9;23:e935839. doi: 10.12659/AJCR.935839.
9
Pericarditis after SARS-CoV-2 Infection: Another Pebble in the Mosaic of Long COVID?新型冠状病毒感染后的心包炎:长新冠的又一拼图?
Viruses. 2021 Oct 4;13(10):1997. doi: 10.3390/v13101997.
10
Closed pericardial drainage for relief of pericardial tamponade.闭式心包引流术用于缓解心包填塞。
Thorac Cardiovasc Surg. 1986 Feb;34(1):66-7. doi: 10.1055/s-2007-1020377.

引用本文的文献

1
Investigating the relationship between the immune response and the severity of COVID-19: a large-cohort retrospective study.探究免疫反应与新型冠状病毒肺炎严重程度之间的关系:一项大型队列回顾性研究
Front Immunol. 2025 Jan 8;15:1452638. doi: 10.3389/fimmu.2024.1452638. eCollection 2024.
2
Clinical and echocardiographic findings in patients with COVID-19 across different severity levels.不同严重程度的 COVID-19 患者的临床和超声心动图表现。
J Med Life. 2023 Nov;16(11):1692-1700. doi: 10.25122/jml-2023-0206.
3
Hyepereosiniphilic syndrome and COVID-19: 2 case reports.

本文引用的文献

1
Insights into neurological dysfunction of critically ill COVID-19 patients.对危重症新冠病毒疾病患者神经功能障碍的见解
Trends Anaesth Crit Care. 2021 Feb;36:30-38. doi: 10.1016/j.tacc.2020.09.005. Epub 2020 Sep 15.
2
The signal pathways and treatment of cytokine storm in COVID-19.新型冠状病毒肺炎中细胞因子风暴的信号通路与治疗策略。
Signal Transduct Target Ther. 2021 Jul 7;6(1):255. doi: 10.1038/s41392-021-00679-0.
3
Cardiac sequelae after coronavirus disease 2019 recovery: a systematic review.新冠病毒病 2019 康复后的心脏后遗症:系统评价。
嗜酸性粒细胞增多综合征与 COVID-19:2 例报告。
J Cardiothorac Surg. 2023 Apr 21;18(1):158. doi: 10.1186/s13019-023-02241-1.
4
Quality of Life in COVID-Related ARDS Patients One Year after Intensive Care Discharge (Odissea Study): A Multicenter Observational Study.重症监护出院一年后新冠相关急性呼吸窘迫综合征患者的生活质量(奥德赛研究):一项多中心观察性研究
J Clin Med. 2023 Jan 29;12(3):1058. doi: 10.3390/jcm12031058.
5
Low dose ultra-slow infusion thrombolytic therapy (LDUSITT) as an alternative option in a COVID-19 patient with free-floating right atrial thrombus: a case report and review of literature.低剂量超慢速输注溶栓疗法(LDUSITT)作为一名患有游离右心房血栓的新冠肺炎患者的替代治疗方案:一例病例报告及文献综述
Thromb J. 2023 Jan 30;21(1):12. doi: 10.1186/s12959-023-00457-8.
6
Subacute Cardiac Tamponade in a COVID-19 Patient Despite Negative Testing.一名新冠病毒检测呈阴性的患者出现亚急性心脏压塞
Cureus. 2022 Sep 12;14(9):e29090. doi: 10.7759/cureus.29090. eCollection 2022 Sep.
7
The Variable Nature of Vitamin C-Does It Help When Dealing with Coronavirus?维生素C的多变性质——应对冠状病毒时它有帮助吗?
Antioxidants (Basel). 2022 Jun 24;11(7):1247. doi: 10.3390/antiox11071247.
8
Admission vital signs as predictors of COVID-19 mortality: a retrospective cross-sectional study.入院生命体征预测 COVID-19 死亡率:一项回顾性横断面研究。
BMC Emerg Med. 2022 Apr 29;22(1):68. doi: 10.1186/s12873-022-00631-7.
Clin Microbiol Infect. 2021 Sep;27(9):1250-1261. doi: 10.1016/j.cmi.2021.06.015. Epub 2021 Jun 23.
4
Pericardial Diseases in COVID19: a Contemporary Review.COVID19 相关的心包疾病:当代综述。
Curr Cardiol Rep. 2021 Jun 3;23(7):90. doi: 10.1007/s11886-021-01519-x.
5
Pericarditis in patients with COVID-19: a systematic review.COVID-19 相关心包炎:系统综述。
J Cardiovasc Med (Hagerstown). 2021 Sep 1;22(9):693-700. doi: 10.2459/JCM.0000000000001202.
6
The Surviving Sepsis Campaign: Research Priorities for Coronavirus Disease 2019 in Critical Illness.《拯救脓毒症运动:危重症 2019 冠状病毒病研究重点》。
Crit Care Med. 2021 Apr 1;49(4):598-622. doi: 10.1097/CCM.0000000000004895.
7
COVID-19 myopericarditis with cardiac tamponade in the absence of respiratory symptoms: a case report.COVID-19 导致的心包积液压塞性心肌炎,无呼吸系统症状:病例报告。
J Med Case Rep. 2021 Jan 25;15(1):31. doi: 10.1186/s13256-020-02618-z.
8
Acute perimyocarditis with cardiac tamponade in COVID-19 infection without respiratory disease.新型冠状病毒肺炎(COVID-19)感染且无呼吸道疾病情况下伴心脏压塞的急性心包心肌炎
BMJ Case Rep. 2020 Aug 19;13(8):e236218. doi: 10.1136/bcr-2020-236218.
9
Epidemiology of COVID-19: A systematic review and meta-analysis of clinical characteristics, risk factors, and outcomes.COVID-19 流行病学:临床特征、危险因素和结局的系统评价和荟萃分析。
J Med Virol. 2021 Mar;93(3):1449-1458. doi: 10.1002/jmv.26424. Epub 2020 Aug 25.
10
Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19.血管紧张素转化酶 2(ACE2)在 COVID-19 中的作用。
Crit Care. 2020 Jul 13;24(1):422. doi: 10.1186/s13054-020-03120-0.